NEUROENDOCRINE TUMOR
Clinical trials for NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced cancers: immunotherapy drug shows promise in large trial
Disease control OngoingThis study tests the drug pembrolizumab in about 1,600 people with advanced solid tumors that have not responded to standard treatments. The goal is to see if the drug can shrink tumors and to identify biomarkers that predict response. Participants receive pembrolizumab and are m…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New hope for neuroendocrine tumors: cabozantinib shows promise in Late-Stage trial
Disease control OngoingThis phase 3 study tests the drug cabozantinib against a placebo in 298 people with advanced neuroendocrine tumors (including carcinoid tumors) that have worsened after prior treatment. Cabozantinib is a targeted therapy that may slow or stop tumor growth by blocking certain prot…
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Major trial tests two drug cocktails for rare gut cancers
Disease control OngoingThis study compares two drug combinations for people with advanced neuroendocrine tumors (a type of slow-growing cancer). 427 participants received either octreotide plus interferon or octreotide plus bevacizumab. The goal is to see which combination better delays cancer growth. …
Matched conditions: NEUROENDOCRINE TUMOR
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New registry aims to improve detection of rare tumors
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a registry for people with neuroendocrine tumors (NETs), a rare type of cancer. Researchers will collect medical data and blood samples from 400 participants to study how well certain blood tests can detect tumor activity, recurrence, and treatment response. The goa…
Matched conditions: NEUROENDOCRINE TUMOR
Sponsor: Wren Laboratories LLC • Aim: Knowledge-focused
Last updated May 26, 2026 09:43 UTC